Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed COO Employment agrmnt
|
TCR2 THERAPEUTICS INC. (TCRR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/01/2023 |
4
| Allen Andrew R (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 16,800 options to buy
@ $0.97, valued at
$16.3k
Disposed/sold 12,100 options to buy
@ $5.21, valued at
$63k
Disposed/sold 12,100 options to buy
@ $31.83, valued at
$385.1k
Disposed/sold 5,000 options to buy
@ $16.1, valued at
$80.5k
Disposed/sold 6,270 options to buy
@ $16.11, valued at
$101k
Disposed/sold 8,072 options to buy
@ $6.07, valued at
$49k
|
|
06/01/2023 |
4
| Tomasello Shawn (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 16,800 options to buy
@ $0.97, valued at
$16.3k
Disposed/sold 12,100 options to buy
@ $5.21, valued at
$63k
Disposed/sold 15,191 options to buy
@ $26.33, valued at
$400k
Disposed/sold 4,177 options to buy
@ $26.33, valued at
$110k
|
|
06/01/2023 |
4
| Sullivan Eric (CFO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 40,820 options to buy
@ $0.97, valued at
$39.6k
Disposed/sold 250,000 options to buy
@ $2.89, valued at
$722.5k
Disposed/sold 6,804 restricted stock units
@ $0 |
|
06/01/2023 |
4
| Cardama Alfonso Quintas (Chief Medical Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 109,459 shares
@ $0 Disposed/sold 70,649 options to buy
@ $0.97, valued at
$68.5k
Disposed/sold 31,582 options to buy
@ $0.74, valued at
$23.4k
Disposed/sold 42,346 options to buy
@ $0.74, valued at
$31.3k
Disposed/sold 90,720 options to buy
@ $5.88, valued at
$533.4k
Disposed/sold 114,700 options to buy
@ $5.21, valued at
$597.6k
Disposed/sold 11,775 restricted stock units
@ $0 Disposed/sold 1,409 restricted stock units
@ $0 Disposed/sold 6,489 restricted stock units
@ $0 Disposed/sold 9,549 restricted stock units
@ $0 |
|
06/01/2023 |
4
| Olagunju Peter (COO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 24,092 shares
@ $0 Disposed/sold 98,124 options to buy
@ $0.97, valued at
$95.2k
Disposed/sold 47,100 options to buy
@ $5.21, valued at
$245.4k
Disposed/sold 16,354 restricted stock units
@ $0 Disposed/sold 62,047 restricted stock units
@ $0 |
|
06/01/2023 |
4
| Webster Stephen W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 16,800 options to buy
@ $0.97, valued at
$16.3k
Disposed/sold 12,100 options to buy
@ $31.83, valued at
$385.1k
Disposed/sold 12,100 options to buy
@ $5.21, valued at
$63k
Disposed/sold 10,482 options to buy
@ $9.54, valued at
$100k
|
|
06/01/2023 |
4
| Harrison Rosemary (Chief Business & Strategy) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 76,930 options to buy
@ $0.97, valued at
$74.6k
Disposed/sold 12,822 restricted stock units
@ $0 Disposed/sold 191,102 options to buy
@ $4.04, valued at
$772.1k
|
|
06/01/2023 |
4
| Menzel Garry E (President and CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 132,729 shares
@ $0 Disposed/sold 132,730 shares
@ $0 Disposed/sold 138,871 shares
@ $0 Disposed/sold 138,031 options to buy
@ $0.74, valued at
$102.1k
Disposed/sold 433,037 options to buy
@ $5.88, valued at
$2.5M
Disposed/sold 305,800 options to buy
@ $5.21, valued at
$1.6M
Disposed/sold 238,008 options to buy
@ $0.97, valued at
$230.9k
Disposed/sold 3,241 restricted stock units
@ $0 Disposed/sold 15,120 restricted stock units
@ $0 Disposed/sold 23,165 restricted stock units
@ $0 Disposed/sold 39,681 restricted stock units
@ $0 |
|
06/01/2023 |
4
| Justice Angela (Chief People Officer) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 48,745 shares
@ $0 Disposed/sold 78,499 options to buy
@ $0.97, valued at
$76.1k
Disposed/sold 76,500 options to buy
@ $5.21, valued at
$398.6k
Disposed/sold 13,083 restricted stock units
@ $0 Disposed/sold 13,527 restricted stock units
@ $0 Disposed/sold 1,050 restricted stock units
@ $0 Disposed/sold 6,336 restricted stock units
@ $0 |
|
06/01/2023 |
4
| Hoos Axel (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 16,800 options to buy
@ $0.97, valued at
$16.3k
Disposed/sold 9,596 options to buy
@ $10.42, valued at
$100k
Disposed/sold 12,100 options to buy
@ $31.83, valued at
$385.1k
Disposed/sold 12,100 options to buy
@ $5.21, valued at
$63k
|
|
06/01/2023 |
4
| Hegde Priti (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 16,800 options to buy
@ $0.97, valued at
$16.3k
Disposed/sold 12,100 options to buy
@ $5.21, valued at
$63k
Disposed/sold 24,968 options to buy
@ $16.02, valued at
$400k
|
|
06/01/2023 |
4
| Gibson Neil W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Disposed/sold 16,800 options to buy
@ $0.97, valued at
$16.3k
Disposed/sold 6,270 options to buy
@ $16.11, valued at
$101k
Disposed/sold 5,000 options to buy
@ $16.1, valued at
$80.5k
Disposed/sold 12,100 options to buy
@ $31.83, valued at
$385.1k
Disposed/sold 12,100 options to buy
@ $5.21, valued at
$63k
Disposed/sold 8,072 options to buy
@ $6.07, valued at
$49k
|
|
05/30/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Bought 50,000 shares
@ $1.72, valued at
$86k
|
|
05/24/2023 |
4
| MPM ASSET MANAGEMENT LLC (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Sold 70,170 shares
@ $1.88, valued at
$131.9k
Exercised (in-or-at-the-money) 42,761 warrants
@ $0.74, valued at
$31.6k
Exercised (in-or-at-the-money) 135,508 warrants
@ $0.74, valued at
$100.3k
|
|
05/24/2023 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Sold 70,170 shares
@ $1.88, valued at
$131.9k
Exercised (in-or-at-the-money) 42,761 warrants
@ $0.74, valued at
$31.6k
Exercised (in-or-at-the-money) 135,508 warrants
@ $0.74, valued at
$100.3k
|
|
05/15/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Bought 38,765 shares
@ $1.95, valued at
$75.6k
Bought 6,183 shares
@ $1.95, valued at
$12.1k
|
|
05/10/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Bought 57,073 shares
@ $1.95, valued at
$111.3k
Bought 20,141 shares
@ $1.95, valued at
$39.3k
Bought 6,774 shares
@ $1.95, valued at
$13.2k
|
|
05/05/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns:
| Bought 18,513 shares
@ $1.85, valued at
$34.2k
Bought 104,241 shares
@ $1.86, valued at
$193.9k
Bought 95,759 shares
@ $1.9, valued at
$181.9k
Bought 71,064 shares
@ $1.94, valued at
$137.9k
|
|
05/05/2023 |
3
| TANG KEVIN C (10% Owner) has filed a Form 3 on TCR2 THERAPEUTICS INC. |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|